EU-based manufacturer of Class II medical devices with a CE mark seeks GRP as partner in USA to support the registration process US FDA via 510(k) pathway.
Taiwan based biotech company wishes to continue IND clinical study phase 2 of study in USA by using Phase 1 data in Taiwan. Client seeks GRP as US agent.
A large US-based pharmaceutical company that was in a process of registering one of its new drugs in China requests GRP to conduct for a GMP Mock-up.
US based Tele-Densitry client seeking partner for global access and regulatory strategy for getting registration of cosmetic product in EU.
Hong Kong based pharmaceutical company requests support for ANDA submission for generic drug along with a US local agent who can respond to US FDA queries.